Sam Isaly
About Sam Isaly
Sam Isaly is the Founder and Chairman Emeritus of OrbiMed and currently serves as Managing Partner at Exome Asset Management. With over 45 years of experience in global healthcare investing, he has held significant roles at major financial institutions and has a strong academic background in economics and mathematics.
Work at OrbiMed Advisors
Sam Isaly has served as the Founder and Chairman Emeritus of OrbiMed Advisors since its inception in 1989. Under his leadership, OrbiMed has become a prominent investment firm specializing in healthcare. Isaly's role has been pivotal in shaping the firm's strategic direction and investment philosophy. He also served as the portfolio manager of Worldwide Healthcare Trust Plc for 22 years, contributing to the firm's reputation in global healthcare investing. His extensive experience in the sector has guided OrbiMed's investment strategies and portfolio management.
Current Role at Exome Asset Management
Since 2018, Sam Isaly has been the Managing Partner at Exome Asset Management, a firm he founded that focuses on healthcare investments. His leadership at Exome reflects his commitment to advancing investment strategies within the healthcare sector. Isaly's extensive background in pharmaceutical analysis and healthcare investing informs the firm's approach to identifying and capitalizing on market opportunities. His work at Exome continues to build on his over 45 years of experience in the industry.
Education and Expertise
Sam Isaly studied at Princeton University, where he earned an A.B. in Economics and Mathematics. He furthered his education at The London School of Economics and Political Science (LSE), obtaining an M.Sc (Econ.) in Economics and Econometrics. This strong academic foundation has equipped Isaly with the analytical skills necessary for a successful career in global healthcare investing. His educational background complements his extensive professional experience, enhancing his expertise in financial analysis and investment strategies.
Professional Background
Sam Isaly has a diverse professional background in the financial services sector, having worked as a pharmaceutical analyst at several prestigious firms, including Chase Manhattan Bank, Merrill Lynch, Legg Mason, and S.G. Warburg. His career spans over 45 years, during which he has developed a deep understanding of healthcare markets and investment dynamics. This experience has positioned him as a knowledgeable leader in healthcare investing, influencing both his work at OrbiMed and Exome Asset Management.